Overview
Employees
11-50
Total raised
$12M
Founded date
2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 19
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 27, 2022 | Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis | SHANGHAI, China, July 27, 2022 /PRNewswire/ -- As the investment division of Viva Biotech, Viva BioInnovator is committed to being a collaborative platform for Innovative Biotech companies from around the world. Over the past 2 month, its p... |
| May 11, 2022 | Global Drug Discovery Software market valued at $2 billion in 2020, is expected to grow at a CAGR of 14% to cross $3.5 billion by 2025 | Medi-Tech Insights: The global Drug Discovery Software market is driven by growing R&D spending's, need for cost-efficiency & faster time-to-market, stringent regulatory compliance/reporting, growing use of AI & ML in drug disco... |
| May 11, 2022 | Global Drug Discovery Software market valued at $2 billion in 2020, is expected to grow at a CAGR of 14% to cross $3.5 billion by 2025 | BRUSSELS, BELGIUM, May 11, 2022 (GLOBE NEWSWIRE) -- Description: The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding sc... |
| Jan 19, 2022 | Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé Farmaceutici Using Exscalate's AI Supercomputing Power to Advance its Drug Discovery Pipeline in Fibrosis and Cancer | Engitix Ltd (‘Engitix’), a biopharmaceutical company with a pioneering and proprietary human extracellular matrix (ECM) drug target discovery platform today announced the close of its $54m Series A financing as well as a strategic collabora... |
| Jan 18, 2022 | Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé Farmaceutici Using Exscalate’s AI Supercomputing Power to Advance its Drug Discovery Pipeline in Fibrosis and Cancer | $54m series A financing co-led by existing investor Netherton Investments (a fund investing on behalf of Mike Platt) and new investor Dompé farmaceutici S.P.A (an Italian and US-based biopharmaceutical company) Multi-year, multi-programme s... |
| Jan 4, 2022 | Will Silicon Valley finally change after the Elizabeth Holmes verdict? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. After a four-month-long trial, Elizabeth Holmes of the now-defunct blood testing startup Theranos... |
| Jan 3, 2022 | Amberstone Biosciences Secures $12 Million Series A Financing To Advance Immuno-Oncology Pipeline Of Tumor Microenvironment Activated Therapeutics | Amberstone Biosciences, an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, announced the completion of a $12 million Series A financing round. The funding was led by Viva BioInnovator, Co-w... |
| Jan 3, 2022 | Amberstone Biosciences Raises $12M in Series A Financing | Amberstone Biosciences, a Laguna Hills, CA-based biotherapeutics company with unique expertise in conditionally active immunotherapeutics, closed a $12m Series A financing round. The round was led by Viva BioInnovator, Co-win Ventures and S... |
| Jan 3, 2022 | Biotech startup Amberstone Biosciences raises $12M Series A to develop immunotherapeutics to treat solid tumor cancers and other diseases | Amberstone Biosciences, a Laguna Hills, California-based biotech startup that is focused on discovering novel immunotherapies, announced today it has secured $12 million in Series A funding to develop immunotherapeutics to treat solid tumor... |
Show more
Reviews 0
FAQ about Drug Discovery
When was Drug Discovery founded?
Drug Discovery was founded in 2018.
How much funding has Drug Discovery raised?
Drug Discovery has raised $12M in total across 1 funding round.
What has the press written about Drug Discovery?
Parsers VC has collected 19 articles mentioning Drug Discovery, among them “Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis” (Jul 27, 2022) and “Global Drug Discovery Software market valued at $2 billion in 2020, is expected to grow at a CAGR of 14% to cross $3.5 billion by 2025” (May 11, 2022).
Is Drug Discovery still active?
Yes, Drug Discovery is active; its latest activity on Parsers VC dates from Dec 13, 2024.